Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
Rhea-AI Summary
Resmed (NYSE:RMD) and Oura announced a partnership to expand access to sleep health education and care pathways for Oura Ring members in the U.S.
Oura Ring Gen3 and Ring 4 users with active memberships can access Resmed educational tools, sleep assessments, and options to connect with independent healthcare providers.
Positive
- None.
Negative
- None.
News Market Reaction – RMD
In the May 19 session, RMD gained 1.78%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 30 | CFO transition | Negative | -4.1% | CFO retirement and succession plan with outlook reiterated. |
| Apr 30 | Quarterly earnings | Positive | -4.1% | Q3 FY2026 revenue, margin and EPS growth update. |
| Apr 01 | Earnings schedule | Neutral | +0.6% | Announcement of date and webcast for Q3 FY2026 results. |
| Mar 03 | Sleep survey data | Positive | +0.3% | Global sleep survey highlighting awareness and behavior gaps. |
| Feb 24 | U.S. expansion | Positive | -3.5% | New Greenwood distribution center to expand logistics capacity. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news shows mixed reactions: strong earnings and expansion updates sometimes saw negative price moves, while survey and scheduling news had modest positive responses.
Over the last few months, ResMed reported strong Q3 FY2026 results with revenue of $1.431B and higher EPS, yet shares fell about 4.11%. A CFO transition announcement on Apr 30 also coincided with a similar decline. Earlier, scheduling its Q3 earnings call and releasing a 2026 Global Sleep Survey produced small gains, while news of a new Greenwood distribution center, expected to employ 100+ workers and lift 2‑day transit coverage to 90%, saw shares down about 3.51%. Today’s ŌURA partnership continues the theme of expanding sleep‑health reach.
Key Terms
obstructive sleep apnea medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Oura Members can take action on changes in sleep or breathing patterns through educational resources from Resmed and pathways for accessing care
SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, and ŌURA, maker of the world’s leading smart ring, today announced they are partnering to expand access to sleep health education and pathways to care, helping more people sleep better and improve their overall health.
Sleep is increasingly recognized as a key pillar of long-term health, yet it remains widely underprioritized.1 Early signs of poor sleep are often dismissed, creating a gap between what people experience and when they seek support or clinical care.
At the same time, the use of wearable technology to track sleep is on the rise, increasing from
Oura Members who experience a higher number of nighttime breathing disturbances can easily connect to trusted resources from Resmed, including:
- Educational resources and a sleep assessment to understand more about sleep health.
- The option to connect with an independent healthcare provider, virtually or in-person, to address their sleep concerns.
- An informative guide to support discussions with their healthcare provider.
By connecting consumer-generated wellness insights with Resmed’s sleep health resources, Resmed and Oura are helping Oura Members take a more informed next step to better understand their sleep health.
"We're at an inflection point in how people engage with their sleep health, driven by rising awareness and more accessible technology," said Dr. Carlos Nunez, chief medical officer at Resmed. "By partnering with ŌURA, we are turning insight into action by guiding people across their sleep health journey and making it easier for them to seek clinical evaluation and care if they have concerns about their sleep.”
“High-quality sleep is one of the strongest foundations for long-term health, yet many people live for years with unrecognized sleep and breathing issues," said Dr. Ricky Bloomfield, chief medical officer at Oura. “By pairing Oura’s continuous insights into sleep and nighttime breathing with Resmed’s sleep expertise, we’re giving people clearer tools and education to spot when something might be off and to more easily access care so they can better understand and act on changes in their sleep health.”
Resmed’s connection with Oura is designed to reach individuals who may not recognize their sleep issues or engage with the healthcare system, making it easier for people to learn about their sleep health and connect with clinical resources when they need it. The experience is available to users of Oura Ring Gen3 and Oura Ring 4 who have an active Oura Membership in the U.S.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
About ŌURA
ŌURA delivers personalized health data, insights, and daily guidance with Oura Ring, the leading smart ring that helps you live healthier, longer. Guided by a mission to shift healthcare from sick care to prevention, ŌURA supports millions of members worldwide across sleep, activity, stress, readiness, women’s health, and heart health. Scientifically validated against medical gold standards, the lightweight Oura Ring tracks 50+ health metrics continuously, empowering both individuals and thousands of research teams, healthcare providers, and organizations. With 1,000 ecosystem partners across wellness and medicine, ŌURA is advancing the future of preventative health.
Founded in Finland in 2013, ŌURA has U.S. headquarters in San Francisco and E.U. headquarters in Oulu. ŌURA was last valued at approximately
Oura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor, or prevent medical conditions or illnesses.
| Contacts | |
| Resmed | |
| For Media | For Investors |
| Caela Shay | Salli Schwartz |
| Caela.shay@resmed.com | Salli.Schwartz@resmed.com |
| news@resmed.com | investorrelations@resmed.com |
| Oura | |
| press@ouraring.com | |
1 Resmed Global Sleep Survey 2026. Available at: sleepsurvey.resmed.com
2 Resmed Global Sleep Survey 2025. Available at: sleepsurvey.resmed.com
3 Resmed Global Sleep Survey 2026. Available at: sleepsurvey.resmed.com
4 Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical Practice. Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017
